Wegovy in New York, NY — pricing, telehealth, coverage

1. Insurance + retail pharmacy

If you have commercial insurance or Medicare that includes Wegovy on formulary, your physician or telehealth provider can send a prescription to any major retail pharmacy in New York: CVS, Walgreens, Walmart, Costco, or grocery-store pharmacy counters. Copays depend on your plan's tier placement and any prior-authorization requirements. For weight-loss indications, expect prior authorization documenting BMI thresholds (typically ≥30, or ≥27 with comorbidities) and often documented lifestyle intervention.

2. Telehealth providers serving New York

Multiple telehealth providers are licensed to prescribe Wegovy to NY residents. These services typically include the medical consultation, ongoing follow-up, and a prescription sent to a pharmacy of your choice or to an affiliated mail-order pharmacy. New York requires a synchronous (live) video consultation for a new GLP-1 prescription — confirm the requirement with the provider. See our provider directory to compare all GLP-1 telehealth providers by price and drug menu — then confirm NYlicensure on the provider's own site (most large telehealth providers cover all or nearly all states).

3. Manufacturer savings programs

Novo Nordisk operates NovoCare, a direct-pay program with uniform national pricing for eligible self-pay patients of Wegovy. NovoCare pricing applies in New York the same as anywhere else in the US. Eligibility criteria typically include US residency, prescription for an FDA-approved indication, and proof of self-pay status (no insurance billing for this fill).

4. Compounded semaglutide (if available)

Compounded semaglutide is offered by some telehealth providers serving New York. Compounded GLP-1 medications are NOT FDA-approved as finished products. FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage in February 2025, which constrains commercial-scale compounding under FDCA §503B; patient-specific compounding under §503A remains permitted in narrow circumstances. See our compounded GLP-1 buyer guide for current safety considerations.

State-level coverage patterns for Wegovy in New York:

• Medicaid: New York Medicaid generally covers Wegovy for FDA-approved chronic weight management with prior authorization. Weight-loss coverage varies — many state Medicaid programs have stricter criteria for weight-loss indications.
• Medicare: Medicare Part D does not cover GLP-1 medications prescribed for weight loss (statutory exclusion under SSA §1860D-2(e)(2)(A)). T2D coverage of Ozempic, Mounjaro, and Rybelsus is available with prior auth. Wegovy received a Medicare Part D coverage path for adults with established cardiovascular disease and overweight/obesity following the SELECT trial label expansion.
• Commercial: Coverage varies dramatically by employer plan design, particularly for weight-loss indications. Many self-funded ASO employer plans exclude anti-obesity medications. Verify with your specific plan.

For a structured state-by-state coverage breakdown, see our pricing-by-state map and payer-coverage guides.